Spirosonic Air Lung device, page-20

Well said Bill - Your post describes my thoughts exactly. I too am very happy to soak up more UCM shares at current prices - and all the better if they drop a bit more.
I am looking forward to what I see as significant developments that should become obvious by the end of this year. The company has already advised shareholders it is setting up a Chinese manufacturing structure to produce its new product range at scale. It is obvious this means improved detailed design, lower manufacturing costs and better margins. The classic USCOM 1A, with its already established reputation, is being improved and specialist additional models produced to target additional specific markets. A new range of products will join the 1A.

The recent Cap Raise provided funds to enable UCM to source and partner with, or take over, an an existing complimentary Chinese scientific instrument manufacturer who will also likely bring additional products to the table. From "reading between the lines", I perceive there is a lot of interest in China in partnering with Uscom and a lot of interest from outside companies in seeking access through Uscom to Chinese markets.

UCM has no debt - it has quietly migrated from a small Australian company to an International company structure focused on Europe, China, Asia and USA. All under the Radar. This planned program was completed with the recent opening of the Singapore Office. Operations in China and Europe are, I believe, now cash-flow positive.

Those who think that this year - will be more of the same for UCM - could be in for a big surprise!!